Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

This study is currently recruiting participants.
Verified February 2014 by VU University Medical Center
Sponsor:
Collaborators:
Dutch Cancer Society
Novartis
Information provided by (Responsible Party):
Hans J. van der Vliet, MD, PhD, VU University Medical Center
ClinicalTrials.gov Identifier:
NCT01462214
First received: October 10, 2011
Last updated: February 19, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)
No publications provided by VU University Medical Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):